FDA Inspection
Diamondback Drugs of Delaware, LLCDiamondback Drugs of Delaware, LLC – FDA Inspection, May 17, 2013
Record Details
This FDA Inspection record concerns Diamondback Drugs of Delaware, LLC, with an inspection on May 17, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- May 17, 2013
- Product Type
- Drugs
View Company Profile
ID · e2d00d24-0e67-4590-8f00-705ec02f7391
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 832692
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
9- 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
- 21 CFR 211.188(b)(3)Identification of each component or in-process material
- 21 CFR 211.182Specific information required in individual logs
- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.113(b)Validation lacking for sterile drug products
- 21 CFR 211.28(a)Protective Apparel Not Worn
- 21 CFR 211.166(a)Lack of written stability program
- 21 CFR 211.42(c)Defined areas of adequate size for operations
- 21 CFR 211.192No written record of investigation
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.